AstraZeneca and Oxford Vaccine Gets Authorization From European Commission; Europeans to get the jab soon
The European Commission on Friday gave a green light to AstraZeneca/Oxford vaccine for people 18 years and above.
The European Commission on Friday gave a green light to AstraZeneca/Oxford vaccine for people 18 years and above.
World Health Organization (WHO) recently issued a clinical advisory to treat COVID-19 patients. Read on to know more.
According to AIIMS Director Dr. Randeep Guleria, the main vaccine side-effects are body ache, fever and pain at injection site, which occur in less than 10 per cent of people and subside in 1-2 days.
The Norwegian Institute of Public Health has issued a cautionary note for the elderly after 23 people above the age of 80 died after receiving Pfizer's COVID-19 vaccine.
Health Minister of Maharashtra, Rajesh Tope said on Wednesday that the 'Covishield' vaccine will not to administered to people under the age of 18, pregnant women and those with allergies.
Public health experts believe that nasal COVID vaccine could be the potential gamechanger in India's fight against coronavirus.
A 32-year-old Mexican doctor experienced seizures, difficulty breathing and a skin rash after receiving the Pfizer-BioNTech COVID-19 vaccine.
The US vaccination programme aims to cover 100 million people by April. Meanwhile, a survey reveals that younger adults were more likely than older population to express willingness to get the COVID-19 vaccine.
Prime Minister Lee Hsien Loong said that the vaccines would be free, voluntary and given first to healthcare workers and the elderly, like him.
"People with a history of significant allergic reactions should not be given the Pfizer/BioNTech Covid vaccine," UK health authorities said on Wednesday.
In its EUA application submitted to the DCGI, Pfizer India has sought permission to import its vaccine for sale and distribution in the country.
The United States is planning to distribute 6.4 million doses of the Pfizer'S Covid-19 vaccine in the first week after it is cleared for emergency use, which is likely next month.
A Lancet report suggests that Sputnik V can be a strong weapon against the novel coronavirus while the Russian government discloses that it is in talks with India for the local production of this COVID-19 vaccine.
Sputnik V, Russia's COVID-19 vaccine is approved for distribution before completing the all-too-crucial Phase III clinical trial. Read on to know how it functions, the safety issues and much more.
Recent research finds that women's immune response to an infection, including COVID-19, is stronger than men. Does this mean they will respond to vaccines better than men? Read on to find out.
Media reports suggest, Covishield will be ready for commercial use in India within 73 days. Here's what you should know about this COVID-19 vaccine, which is supposed to be free for Indians.
Russia has launched the world's first COVID-19 vaccine. But will it be safe? Dr. Anthony Fauci and scientists all over the world are sounding alarm.
US researchers are conducting clinical trials to determine if oral cancer drug ibrutinib can also help patients with immunocompromised conditions recover from COVID-19.
World Health Organization (WHO) recently issued a clinical advisory to treat COVID-19 patients. Read on to know more.
According to AIIMS Director Dr. Randeep Guleria, the main vaccine side-effects are body ache, fever and pain at injection site, which occur in less than 10 per cent of people and subside in 1-2 days.
The Norwegian Institute of Public Health has issued a cautionary note for the elderly after 23 people above the age of 80 died after receiving Pfizer's COVID-19 vaccine.
Health Minister of Maharashtra, Rajesh Tope said on Wednesday that the 'Covishield' vaccine will not to administered to people under the age of 18, pregnant women and those with allergies.
Public health experts believe that nasal COVID vaccine could be the potential gamechanger in India's fight against coronavirus.
A 32-year-old Mexican doctor experienced seizures, difficulty breathing and a skin rash after receiving the Pfizer-BioNTech COVID-19 vaccine.
The US vaccination programme aims to cover 100 million people by April. Meanwhile, a survey reveals that younger adults were more likely than older population to express willingness to get the COVID-19 vaccine.
Prime Minister Lee Hsien Loong said that the vaccines would be free, voluntary and given first to healthcare workers and the elderly, like him.
"People with a history of significant allergic reactions should not be given the Pfizer/BioNTech Covid vaccine," UK health authorities said on Wednesday.
In its EUA application submitted to the DCGI, Pfizer India has sought permission to import its vaccine for sale and distribution in the country.
The United States is planning to distribute 6.4 million doses of the Pfizer'S Covid-19 vaccine in the first week after it is cleared for emergency use, which is likely next month.
A Lancet report suggests that Sputnik V can be a strong weapon against the novel coronavirus while the Russian government discloses that it is in talks with India for the local production of this COVID-19 vaccine.
Sputnik V, Russia's COVID-19 vaccine is approved for distribution before completing the all-too-crucial Phase III clinical trial. Read on to know how it functions, the safety issues and much more.
Recent research finds that women's immune response to an infection, including COVID-19, is stronger than men. Does this mean they will respond to vaccines better than men? Read on to find out.
Media reports suggest, Covishield will be ready for commercial use in India within 73 days. Here's what you should know about this COVID-19 vaccine, which is supposed to be free for Indians.
Russia has launched the world's first COVID-19 vaccine. But will it be safe? Dr. Anthony Fauci and scientists all over the world are sounding alarm.
US researchers are conducting clinical trials to determine if oral cancer drug ibrutinib can also help patients with immunocompromised conditions recover from COVID-19.